VITAMIN C AND UPPER RESPIRATORY ILLNESS IN NAVAHO CHILDREN: PRELIMINARY OBSERVATIONS (1974)

Separately or in combination, antihistamines, decongestants, antitussives, and expectorants are used to treat the cough and rhinitis symptoms of the common cold and of allergies. Each year, Americans spend 1 to 2 billion dollars on cough and cold remedies and lose more than 26 million school days and 23 million work days because of rhinitis and associated symptoms. Studies have shown that antihistamines and decongestants are efficacious in the treatment of allergy symptoms, but the results of studies are mixed regarding their efficacy in the treatment of symptoms of the common cold, and studies show no effect in prevention or treatment of otitis media. Some review articles and consensus opinions do not recommend the use of these drugs in the common cold (especially in preschool children), although some studies have demonstrated symptomatic relief, and physicians continue to prescribe or recommend these drugs for respiratory illness more than 36 million times annually. The Common Cold More than 200 million cases of acute upper respiratory infection (URI) occur each year in the United States, and more than 75 million are seen by physicians. URIs account for 23 million missed work days and 26 million missed school days. This is the second most common diagnosis made by office-based pediatricians, second only to otitis media.

Download Full-text

BENIGN VI NERVE PALSIES IN CHILDREN

PEDIATRICS ◽

10.1542/peds.40.4.560 ◽

1967 ◽

Vol 40 (4) ◽

pp. 560-564

Author(s):

David L. Knox ◽

David B. Clark ◽

Frank F. Schuster

Keyword(s):

Otitis Media ◽

Nerve Palsy ◽

Respiratory Illness ◽

Case Histories ◽

Important Conclusion ◽

Diagnostic Studies ◽

Viral Illness ◽

Upper Respiratory

The case histories of 12 patients who developed a VI nerve palsy after an apparently benign illness have been presented. The palsy developed in children of any age in 7 to 21 days after fever or upper respiratory illness and cleared, in all but one child, within 10 weeks. Two etiologic mechanisms are possible: otitis media and its complications, or neuritis after systemic viral illness. The most important conclusion is that this is a relatively benign entity which first presents with malignant implications. Recognition of this syndrome allows the clinician to cautiously defer complicated diagnostic studies, such as arteriogram and pneumoencephalogram, with the expectation of improvement in the VI nerve palsy.

Download Full-text

Upper respiratory illness in different tiers of rugby union

Sport Sciences for Health ◽

10.1007/s11332-018-0512-8 ◽

2018 ◽

Vol 15 (1) ◽

pp. 197-205 ◽

Cited By ~ 2

Author(s):

Vaughan Somerville ◽

Nicholas D. Gill ◽

Alex Ross ◽

Andrea Braakhuis

Keyword(s):

Respiratory Illness ◽

Rugby Union ◽

Upper Respiratory

Download Full-text

RECOVERY OF PARAINFLUENZA VIRUSES FROM ADULTS WITH UPPER RESPIRATORY ILLNESS

American Journal of Epidemiology ◽

10.1093/oxfordjournals.aje.a120200 ◽

1961 ◽

Vol 74 (1) ◽

pp. 50-59 ◽

Cited By ~ 4

Author(s):

H. H. BLOOM ◽

K. M. JOHNSON ◽

R. JACOBSEN ◽

R. M. CHANOCK

Keyword(s):

Respiratory Illness ◽

Parainfluenza Viruses ◽

Upper Respiratory

Download Full-text

The Effect of Olive Leaf Extract on Upper Respiratory Illness in High School Athletes: A Randomised Control Trial

Nutrients ◽

10.3390/nu11020358 ◽

2019 ◽

Vol 11 (2) ◽

pp. 358 ◽

Cited By ~ 8

Author(s):

Vaughan Somerville ◽

Rachel Moore ◽

Andrea Braakhuis

Keyword(s):

High School ◽

Leaf Extract ◽

Respiratory Illness ◽

Return To Play ◽

Randomised Control Trial ◽

Olive Leaf ◽

High School Athletes ◽

Olive Leaf Extract ◽

Significant Difference ◽

Upper Respiratory

Upper respiratory illness (URI) has a major impact on both training and competition in an athletic setting. High school athletes are a sub-category who have reported higher illness rates than professional and sub-elite high school athletes of the same sport. Olive leaf extract (OLE) is an over-the-counter supplement that contains polyphenols, notably oleuropein and hydroxytyrosol, that have antiviral, antibacterial, anti-inflammatory and antioxidant properties that may reduce URI rates. Thirty-two high school students who play sport for the elite team at their school were recruited to a randomised controlled trial and allocated to a daily placebo or OLE (extent equivalent to 20 g of olive leaf, containing 100 mg oleuropein) supplementation for nine weeks during their competitive season. Twice weekly measures of wellbeing, training load and respiratory illness (sporting upper respiratory illness (SUPPRESS) questionnaire) were recorded at trainings, meetings or games. There was no significant difference in illness incidence (odds ratio (OR): 1.02 (95% confidence interval (CI) 0.21–4.44)), but there was a significant 28% reduction in sick days (OR: 0.72 (95% CI 0.56–0.93) p-value = 0.02) when supplemented with OLE. The dietary intakes of the athletes were sub-optimal with regard to immune support. OLE supplementation over a season did not significantly reduce URI incidence, but did decrease duration in high school athletes, potentially aiding return to play.

Download Full-text

Vitamin C Symposium 2019—“Vitamin C for Cancer and Infection: From Bench to Bedside”

Proceedings ◽

10.3390/proceedings2019005003 ◽

2019 ◽

Vol 5 (1) ◽

pp. 3

Author(s):

Anitra Carr

Keyword(s):

Clinical Trials ◽

Vitamin C ◽

Clinical Outcomes ◽

Respiratory Illness ◽

Severe Respiratory Illness

The Vitamin C for Cancer and Infection symposium was organised in response to recent international clinical trials that have highlighted the potential for vitamin C administration to improve clinical outcomes for patients with severe respiratory illness, sepsis and some cancers [...]

Download Full-text